Authors:
Olianas, MC
Maullu, C
Adem, A
Mulugeta, E
Karlsson, E
Onali, P
Citation: Mc. Olianas et al., Inhibition of acetylcholine muscarinic M-1 receptor function by the M-1-selective ligand muscarinic toxin 7 (MT-7), BR J PHARM, 131(3), 2000, pp. 447-452
Authors:
Fioravanti, R
Biava, M
Porretta, GC
Lampis, G
Maullu, C
Pompei, R
Citation: R. Fioravanti et al., Stereospecific synthesis and antimycobacterial activity of 1-aryl-2-(1H-imidazol-1-yl)-O-(aryl)-ethanoxime ethers E and Z oxiconazole analogs, MED CHEM RE, 9(4), 1999, pp. 249-266
Authors:
Olianas, MC
Maullu, C
Ingianni, A
Onali, P
Citation: Mc. Olianas et al., [Phe(1)Phi(CH2-NH)Gly(2)]nociceptin-(1-13)-NH2 acts as a partial agonist at ORL1 receptor endogenously expressed in mouse N1E-115 neuroblastoma cells, NEUROREPORT, 10(5), 1999, pp. 1127-1131
Citation: Mc. Olianas et al., Mixed agonist-antagonist properties of clozapine at different human clonedmuscarinic receptor subtypes expressed in Chinese hamster ovary cells, NEUROPSYCH, 20(3), 1999, pp. 263-270
Authors:
Maullu, C
Lampis, G
Desogus, A
Ingianni, A
Rossolini, GM
Pompei, R
Citation: C. Maullu et al., High-level production of heterologous protein by engineered yeasts grown in cottage cheese whey, APPL ENVIR, 65(6), 1999, pp. 2745-2747
Authors:
Olianas, MC
Ingianni, A
Maullu, C
Adem, A
Karlsson, E
Onali, P
Citation: Mc. Olianas et al., Selectivity profile of muscarinic toxin 3 in functional assays of cloned and native receptors, J PHARM EXP, 288(1), 1999, pp. 164-170